Hannah Brendan 4
4 · Quince Therapeutics, Inc. · Filed Aug 9, 2023
Insider Transaction Report
Form 4
Hannah Brendan
CBO, COO & CCO
Transactions
- Purchase
Common Stock
2023-08-08$1.22/sh+71,762$87,550→ 201,555 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.